Digestives & Intestinal Remedies - APAC
APAC- In the year 2024, the revenue in the Digestives & Intestinal Remedies market market in the APAC region is projected to reach a substantial amount of US$8.32bn.
- It is estimated that the market will experience an annual growth rate of 2.69% from 2024 to 2028, according to the compound annual growth rate (CAGR).
- When compared to other countries globally, China stands out as the top revenue generator in the Digestives & Intestinal Remedies market market, with a predicted revenue of US$4.41bn in 2024.
- This highlights China's dominant position in this market within the APAC region.
- To put this revenue into perspective, the per capita revenue generated in the Digestives & Intestinal Remedies market market is approximately US$1.94 per person in 2024.
- This figure indicates the average revenue generated per individual based on the total population figures in the APAC region.
- In China, the Digestives & Intestinal Remedies market is experiencing a surge in demand due to the increasing prevalence of gastrointestinal disorders.
- Key regions:
- Canada,
- United States,
- Australia,
- Brazil,
- Japan
Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
In-Scope
- Natural and synthetic agents
- Digestive medicines
- Remedies against gastrointestinal complaints
Out-Of-Scope
- Prescription medicines
- Homeopathic remedies
- Tea
